AU4289193A - Mutant cytokines having increased receptor affinity - Google Patents
Mutant cytokines having increased receptor affinityInfo
- Publication number
- AU4289193A AU4289193A AU42891/93A AU4289193A AU4289193A AU 4289193 A AU4289193 A AU 4289193A AU 42891/93 A AU42891/93 A AU 42891/93A AU 4289193 A AU4289193 A AU 4289193A AU 4289193 A AU4289193 A AU 4289193A
- Authority
- AU
- Australia
- Prior art keywords
- receptor affinity
- increased receptor
- mutant cytokines
- cytokines
- mutant
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Abandoned
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/195—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria
- C07K14/34—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from bacteria from Corynebacterium (G)
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/52—Cytokines; Lymphokines; Interferons
- C07K14/54—Interleukins [IL]
- C07K14/5406—IL-4
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/55—Fusion polypeptide containing a fusion with a toxin, e.g. diphteria toxin
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K2319/00—Fusion polypeptide
- C07K2319/70—Fusion polypeptide containing domain for protein-protein interaction
- C07K2319/74—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor
- C07K2319/75—Fusion polypeptide containing domain for protein-protein interaction containing a fusion for binding to a cell surface receptor containing a fusion for activation of a cell surface receptor, e.g. thrombopoeitin, NPY and other peptide hormones
Landscapes
- Chemical & Material Sciences (AREA)
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Life Sciences & Earth Sciences (AREA)
- Medicinal Chemistry (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Genetics & Genomics (AREA)
- Biochemistry (AREA)
- Molecular Biology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Toxicology (AREA)
- Zoology (AREA)
- Peptides Or Proteins (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US870500 | 1978-01-18 | ||
US87050092A | 1992-04-17 | 1992-04-17 |
Publications (1)
Publication Number | Publication Date |
---|---|
AU4289193A true AU4289193A (en) | 1993-11-18 |
Family
ID=25355515
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
AU42891/93A Abandoned AU4289193A (en) | 1992-04-17 | 1993-04-16 | Mutant cytokines having increased receptor affinity |
Country Status (2)
Country | Link |
---|---|
AU (1) | AU4289193A (en) |
WO (1) | WO1993021308A1 (en) |
Families Citing this family (7)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN1044720C (en) * | 1993-07-07 | 1999-08-18 | 株式会社乐喜 | Modified human granulocyte macrophagecolony stimulating factor gene and expression thereof in yeast |
US5986059A (en) * | 1996-06-14 | 1999-11-16 | Bayer Corporation | T-cell selective interleukin-4 agonists |
HUP9902824A3 (en) * | 1996-06-14 | 2001-11-28 | Bayer Corp Pittsburgh | T-cell selective interleukin-4 agonists |
US6335426B1 (en) | 1996-06-14 | 2002-01-01 | Bayer Corporation | T-cell selective interleukin-4 agonists |
US6028176A (en) * | 1996-07-19 | 2000-02-22 | Bayer Corporation | High-affinity interleukin-4 muteins |
MY124565A (en) * | 1996-07-19 | 2006-06-30 | Bayer Corp | High-affinity interleukin-4-muteins |
AU2728200A (en) * | 1999-01-15 | 2000-08-01 | Zymogenetics Inc. | Mammalian alpha-helical protein - 12 |
-
1993
- 1993-04-16 WO PCT/US1993/003613 patent/WO1993021308A1/en active Application Filing
- 1993-04-16 AU AU42891/93A patent/AU4289193A/en not_active Abandoned
Also Published As
Publication number | Publication date |
---|---|
WO1993021308A1 (en) | 1993-10-28 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
AU1964992A (en) | Solid elastomeric block copolymers | |
AU4397396A (en) | Mutant luciferases | |
AU7599894A (en) | Elevator ride quality | |
AU2482492A (en) | Headset | |
AU8828791A (en) | Electro-hammer rapper | |
AU2484492A (en) | Suspension system | |
AU5285293A (en) | Suspension arrangement | |
AU644498B2 (en) | Damper mechanism | |
AU4377793A (en) | Alternative receptor therapy | |
AU5696694A (en) | Substituted benzazepinones | |
AU1908892A (en) | Assembly apparatus | |
AU1091995A (en) | Hybrid cytokines | |
AU4014193A (en) | Chair | |
AU4289193A (en) | Mutant cytokines having increased receptor affinity | |
AU5112193A (en) | Chair | |
AU5152593A (en) | Video printer | |
AU3897193A (en) | Tilt determination | |
AU6149894A (en) | Dispersion | |
AU4960393A (en) | Sifter | |
AU4703893A (en) | Methanesulphonate | |
AU663916B2 (en) | Pillow | |
AU673139B2 (en) | Tri-hull construction | |
RU2005089C1 (en) | Elevator | |
AU3033592A (en) | Shuttlecar equaliser | |
AU4069293A (en) | Substituted 2-arylpyrroles |